Impact Factor
3.46
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.41
388 total citations
h5-index
31
h5 depth signal
Cited share
74.4%
87 of 117
Total citations
388
Citation footprint
Metric signal
3.41
External metric anchor
Self-citation
0.3%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
212
India
115
China
55
United Kingdom
49
Australia
42
Citing Fields of Research
Cardiology
505
Diabetes
42
Autonomic Function
39
Lipids
32
Vascular Disorders
30
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,203
Articles tracked across the journal lifetime
Indexed publication set
117
87 cited publications
Last 12 months
163
14.8 publications/month
Open access share
25.8%
42 OA publications in the last year
Leading citing country
United States
212 citing publications
Leading citing field
Cardiology
505 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v7n2, May 2011-
v4, 2008-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Broad Categories
Cardiology
MeSH Descriptors
Cardiovascular Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/011573403x491898261006113636
Open DOI
Coronary Artery Calcium Screening: A Narrative Review and Guide to Preventive Strategies
Coronary Artery Calcium (CAC) scoring has become a central tool for detecting subclinical atherosclerosis and refining cardiovascular risk assessment, particularly in individuals with intermediate or atypical risk profiles. Traditional r...
02
DOI 10.2174/011573403x522286260923132142
Open DOI
Endothelial Dysfunction and Inflammatory Pathways in Heart Failure – Role of suPAR and sVCAM-1 as Novel Biomarkers
Introduction: Heart failure (HF) is a multifactorial clinical syndrome characterised by myocardial remodelling, endothelial dysfunction, and chronic inflammation. Emerging evidence highlights the role of inflammatory and endothelial biom...
03
DOI 10.2174/011573403x516185260914073314
Open DOI
Cardio-Hepatic Syndrome in Iron Overload: A Scenario Beyond Alcohol and Metabolic Dysfunction
Liver disease and heart failure have interconnected pathophysiology and frequently coexist within the common framework of systemic metabolic disorder, as a result of alcohol overuse, or as a consequence of one organ’s failure precipitati...
04
DOI 10.2174/011573403x512215260909111132
Open DOI
Chronic Hypertension in Pregnancy: Risk Stratification, Management Strategies and Long-term Maternal-Fetal Outcomes
Introduction/Objectives: Chronic hypertension in pregnancy is increasingly prevalent and is associated with substantial maternal and fetal morbidity, including superimposed preeclampsia, placental abruption, fetal growth restriction, pre...
05
DOI 10.2174/011573403x485322260904063323
Open DOI
Cardiac Implantable Electronic Devices Management in Older Adults ≥75 Years Old: From Underrepresentation in Clinical Trials to Overrepresentation in Contemporary Clinical Practice
Cardiac Implantable Electronic Devices (CIEDs), ranging from Permanent Pacemakers (PPMs) for bradycardia, Implantable Cardioverter-Defibrillators (ICDs), to Cardiac Resynchronization Therapy (CRT) with Pacing (CRT-P) or Defibrillation (C...
06
DOI 10.2174/011573403x475339260903094116
Open DOI
Lung Density: A Computed Tomography Marker for Severity in Pulmonary Hypertension of Various Etiologies
Introduction: To investigate the capabilities of CT markers for assessing the severity of PH and to compare them with PFT and gas exchange parameters. Methods: This single-center study evaluated 90 consecutive Pulmonary Hypertension (PH)...
07
DOI 10.2174/011573403x502569260902101501
Open DOI
Obstructive Sleep Apnea as a Driver of Venous Congestion, Cardio-Renal Dysfunction, and Cardiac Conduction Disease: A Comprehensive Review
Introduction: Obstructive sleep apnea (OSA) represents one of the significant systemic diseases with considerable cardiovascular and renal consequences. Along with the wellknown links of OSA with hypertension and metabolic disorders, gro...
08
DOI 10.2174/011573403x463044260901064703
Open DOI
Ischemic Conditioning in ST-Elevation Myocardial Infarction: A Systematic Review of Randomized Controlled Trials
Introduction: Despite recent developments in the treatment of ST-Elevation Myocardial Infarction (STEMI), there has been an increase in cases of post-infarction heart failure, even though there has been a decrease in mortality rates. A f...
09
DOI 10.2174/011573403x495026260829090437
Open DOI
Beyond Glycemic Control: Multi-pathway Cardioprotective Mechanisms of Selective Na+/glucose Co-transporter 2 Inhibitors with Emerging Implications for Atrial Fibrillation
Introduction: Atrial fibrillation (AF) is the most common form of cardiac arrhythmia and is associated with electrocardiographic changes resulting from several complex mechanisms. While management of AF relies mainly on ion channel block...
10
DOI 10.2174/011573403x493832260820062705
Open DOI
Effect of Impedance-Guided Fluid Therapy on Treatment Outcomes of Patients with Heart Failure: A Systematic Review and Meta-Analysis
Introduction: Traditional volumetric assessment methods have limitations in the management of HF. The clinical value of impedance-guided monitoring (including bioelectrical impedance analysis [BIA], lung/thoracic impedance [LI], or intra...
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 2, no. 3 (Aug. 2006).
Also issued online.